Austin Murata

Array ( [id] => 4522160 [patent_doc_number] => 07951528 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system' [patent_app_type] => utility [patent_app_number] => 11/660070 [patent_app_country] => US [patent_app_date] => 2004-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6181 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951528.pdf [firstpage_image] =>[orig_patent_app_number] => 11660070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5216033 [patent_doc_number] => 20070105114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Biomarkers of cyclin-dependent kinase modulation' [patent_app_type] => utility [patent_app_number] => 10/567867 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 37656 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20070105114.pdf [firstpage_image] =>[orig_patent_app_number] => 10567867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250320 [patent_doc_number] => 20050074452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/894672 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 13407 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074452.pdf [firstpage_image] =>[orig_patent_app_number] => 10894672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5056379 [patent_doc_number] => 20070059301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Modified antibody fragments' [patent_app_type] => utility [patent_app_number] => 10/562807 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10359 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20070059301.pdf [firstpage_image] =>[orig_patent_app_number] => 10562807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905148 [patent_doc_number] => 20050100543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Multivalent carriers of bi-specific antibodies' [patent_app_type] => utility [patent_app_number] => 10/882151 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 52916 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100543.pdf [firstpage_image] =>[orig_patent_app_number] => 10882151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5074827 [patent_doc_number] => 20070014802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Modified antibody fragments' [patent_app_type] => utility [patent_app_number] => 10/562769 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10716 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20070014802.pdf [firstpage_image] =>[orig_patent_app_number] => 10562769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5045602 [patent_doc_number] => 20070264275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Peptides Derived from the Protein Mmp-2, and the Use Thereof in Antitumoral Immunotherapy' [patent_app_type] => utility [patent_app_number] => 10/561951 [patent_app_country] => US [patent_app_date] => 2004-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3260 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20070264275.pdf [firstpage_image] =>[orig_patent_app_number] => 10561951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894454 [patent_doc_number] => 20060002993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 10/859643 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 73529 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002993.pdf [firstpage_image] =>[orig_patent_app_number] => 10859643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142697 [patent_doc_number] => 20070004913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 10/860769 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 73639 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004913.pdf [firstpage_image] =>[orig_patent_app_number] => 10860769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5119936 [patent_doc_number] => 20070141650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Predicting cancer progression' [patent_app_type] => utility [patent_app_number] => 10/555935 [patent_app_country] => US [patent_app_date] => 2004-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9472 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20070141650.pdf [firstpage_image] =>[orig_patent_app_number] => 10555935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 239426 [patent_doc_number] => 07592143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Methods of treating diseases responsive to induction of apoptosis and screening assays' [patent_app_type] => utility [patent_app_number] => 10/826909 [patent_app_country] => US [patent_app_date] => 2004-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 56458 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592143.pdf [firstpage_image] =>[orig_patent_app_number] => 10826909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959685 [patent_doc_number] => 20080274110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Cell Death-Inducing Agents' [patent_app_type] => utility [patent_app_number] => 11/547747 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 15030 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274110.pdf [firstpage_image] =>[orig_patent_app_number] => 11547747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297254 [patent_doc_number] => 20040214788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Treatment of prostate cancer' [patent_app_type] => new [patent_app_number] => 10/797690 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9573 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214788.pdf [firstpage_image] =>[orig_patent_app_number] => 10797690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7152580 [patent_doc_number] => 20050025771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Antitumor agents comprising a targeting portion and an immune response triggering portion' [patent_app_type] => utility [patent_app_number] => 10/792390 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9654 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025771.pdf [firstpage_image] =>[orig_patent_app_number] => 10792390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5742813 [patent_doc_number] => 20060088538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical composition, and diagnostic reagent' [patent_app_type] => utility [patent_app_number] => 10/546594 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14252 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088538.pdf [firstpage_image] =>[orig_patent_app_number] => 10546594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655736 [patent_doc_number] => 20060141471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Assay for detection of renal cell carcinoma' [patent_app_type] => utility [patent_app_number] => 10/546435 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17078 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141471.pdf [firstpage_image] =>[orig_patent_app_number] => 10546435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 895739 [patent_doc_number] => 07342105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Antibody and use thereof' [patent_app_type] => utility [patent_app_number] => 10/547051 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17246 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/342/07342105.pdf [firstpage_image] =>[orig_patent_app_number] => 10547051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5595777 [patent_doc_number] => 20060159693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-20 [patent_title] => 'Idiotypic vaccine' [patent_app_type] => utility [patent_app_number] => 10/546901 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10636 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20060159693.pdf [firstpage_image] =>[orig_patent_app_number] => 10546901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7135960 [patent_doc_number] => 20050180979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Anti-EpCAM immunoglobulins' [patent_app_type] => utility [patent_app_number] => 10/778915 [patent_app_country] => US [patent_app_date] => 2004-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9789 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20050180979.pdf [firstpage_image] =>[orig_patent_app_number] => 10778915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7181217 [patent_doc_number] => 20040202651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'Uses of anti-insulin-like growth factor 1 receptor antibodies' [patent_app_type] => new [patent_app_number] => 10/775444 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11474 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20040202651.pdf [firstpage_image] =>[orig_patent_app_number] => 10775444 [rel_patent_id] =>[rel_patent_doc_number] =>)